Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04040 (
Catalase
)
3,577
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leukemia inhibitory factor
(
LIF
) is a cytokine, which inhibits angiogenesis and decreases endothelial cell proliferation and migration, suggesting that
LIF
may modulate vascular tone. In this study, we examined the effects of
LIF
on the tone of rat arteries. The isometric tension of ring preparations from rat superior mesenteric arteries was continuously measured.
LIF
relaxed the mesenteric arteries in a dose-dependent manner, when the arterial rings were precontracted with phenylephrine. The relaxation was totally inhibited by mechanical removal of endothelium. N(G)-nitro-L-arginine methyl ester did not affect the relaxation by
LIF
. Ca(2+)-dependent K channel (KCa) blockers, apamin with charybdotoxin, inhibited the relaxation by
LIF
.
Catalase
, an enzyme which scavenges hydrogen peroxide, also inhibited the relaxation by
LIF
. Endothelium-derived hyperpolarizing factor relaxes smooth muscle cells and the effect is blocked by KCa and catalase. Our results suggest that
LIF
regulates vascular tone through the effect of this factor.
...
PMID:Leukemia inhibitory factor relaxes arteries through endothelium-dependent mechanism. 1205 20